These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 9120290
1. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. Lee SP, Tierney RJ, Thomas WA, Brooks JM, Rickinson AB. J Immunol; 1997 Apr 01; 158(7):3325-34. PubMed ID: 9120290 [Abstract] [Full Text] [Related]
2. Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients. Whitney BM, Chan AT, Rickinson AB, Lee SP, Lin CK, Johnson PJ. J Med Virol; 2002 Jul 01; 67(3):359-63. PubMed ID: 12116028 [Abstract] [Full Text] [Related]
3. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide. Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y. Oncol Rep; 2004 Oct 01; 12(4):725-31. PubMed ID: 15375491 [Abstract] [Full Text] [Related]
12. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells. Murray RJ, Brooks JM, Rickinson AB, Rowe M. Eur J Immunol; 1990 Mar 01; 20(3):659-64. PubMed ID: 1690661 [Abstract] [Full Text] [Related]
13. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan. Lin HJ, Cherng JM, Hung MS, Sayion Y, Lin JC. J Biomed Sci; 2005 Dec 01; 12(6):925-36. PubMed ID: 16307312 [Abstract] [Full Text] [Related]
14. Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma. Duraiswamy J, Sherritt M, Thomson S, Tellam J, Cooper L, Connolly G, Bharadwaj M, Khanna R. Blood; 2003 Apr 15; 101(8):3150-6. PubMed ID: 12468425 [Abstract] [Full Text] [Related]
17. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Khanna R, Burrows SR, Nicholls J, Poulsen LM. Eur J Immunol; 1998 Feb 15; 28(2):451-8. PubMed ID: 9521052 [Abstract] [Full Text] [Related]
18. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population. Lee SP, Morgan S, Skinner J, Thomas WA, Jones SR, Sutton J, Khanna R, Whittle HC, Rickinson AB. Eur J Immunol; 1995 Jan 15; 25(1):102-10. PubMed ID: 7531142 [Abstract] [Full Text] [Related]
19. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells. Kobayashi H, Nagato T, Takahara M, Sato K, Kimura S, Aoki N, Azumi M, Tateno M, Harabuchi Y, Celis E. Cancer Res; 2008 Feb 01; 68(3):901-8. PubMed ID: 18245493 [Abstract] [Full Text] [Related]
20. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. Solache A, Morgan CL, Dodi AI, Morte C, Scott I, Baboonian C, Zal B, Goldman J, Grundy JE, Madrigal JA. J Immunol; 1999 Nov 15; 163(10):5512-8. PubMed ID: 10553078 [Abstract] [Full Text] [Related] Page: [Next] [New Search]